Home Newsletters Endothelial Cell News Sotatercept Analog Suppresses Inflammation to Reverse Experimental Pulmonary Arterial Hypertension

Sotatercept Analog Suppresses Inflammation to Reverse Experimental Pulmonary Arterial Hypertension

0
Researchers determined through genome-wide expression profiling that inflammatory and immune responses were prominently upregulated in the lungs of a Sugen-hypoxia rat model of severe angio-obliterative pulmonary arterial hypertension (PAH), concordant with profiles observed in PAH patients.
[Scientific Reports]
Full Article
Exit mobile version